Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1

Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases - preliminary results. Radiol Oncol 2010; 44: 92-6.10.2478/v10019-010-0027-7342368522933897Search in Google Scholar

Inan N, Kilinc F, Sarisoy T, Gumustas S, Akansel G, Demirci A. Diffusion weighted MR imaging in the differential diagnosis of haemangiomas and metastases of the liver. Radiol Oncol 2010; 44: 24-29.10.2478/v10019-010-0001-4342367422933887Search in Google Scholar

Horvat M, Novakovic BJ. Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma. Radiol Oncol 2010; 44: 232-8.10.2478/v10019-010-0044-6342370322933921Search in Google Scholar

Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.10.1093/jnci/92.3.20510655437Search in Google Scholar

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47.10.1016/j.ejca.2008.10.02619097774Search in Google Scholar

Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15: 257-60.10.1093/annonc/mdh05914760119Search in Google Scholar

Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574-82.10.1200/JCO.2003.01.14412829678Search in Google Scholar

Darkeh MH, Suzuki C, Torkzad MR. The minimum number of target lesions that need to be measured to be representative of the total number of target lesions (according to RECIST). Br J Radiol 2009; 82: 681-6.10.1259/bjr/7282956319366735Search in Google Scholar

Hillman SL, An MW, O'Connell MJ, Goldberg RM, Schaefer P, Buckner JC, et al. Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation. J Clin Oncol 2009; 27: 3205-10.10.1200/JCO.2008.18.3269291735019414682Search in Google Scholar

Zacharia TT, Saini S, Halpern EF, Sumner JE. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. AJR Am J Roentgenol 2006; 186: 1067-70.10.2214/AJR.05.003816554580Search in Google Scholar

Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I. RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer 2005; 41: 1426-30.10.1016/j.ejca.2005.04.00515919202Search in Google Scholar

Curran SD, Muellner AU, Schwartz LH. Imaging response assessment in oncology. Cancer Imaging 2006; 6: S126-30.10.1102/1470-7330.2006.9039180507617114065Search in Google Scholar

Shanbhogue AK, Karnad AB, Prasad SR. Tumor response evaluation in oncology: current update. J Comput Assist Tomogr 2010; 34: 479-84.10.1097/RCT.0b013e3181db267020657213Search in Google Scholar

Gavrielides MA, Kinnard LM, Myers KJ, Petrick N. Noncalcified lung nodules: volumetric assessment with thoracic CT. Radiology 2009; 251: 26-37.10.1148/radiol.2511071897266358119332844Search in Google Scholar

Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ, et al. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden. Clin Cancer Res 2011; 17: 1181-9.10.1158/1078-0432.CCR-10-192921177406Search in Google Scholar

Gietema HA, Schaefer-Prokop CM, Mali WP, Groenewegen G, Prokop M. Pulmonary nodules: interscan variability of semiautomated volume measurements with multisection CT - influence of inspiration level, nodule size, and segmentation performance. Radiology 2007; 245: 888-94.10.1148/radiol.245206105417923508Search in Google Scholar

Wang Y, de Bock GH, van Klaveren RJ, van Ooyen P, Tukker W, Zhao Y, et al. Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability. Eur Radiol 2010; 20: 1180-7.10.1007/s00330-009-1634-9285052719921204Search in Google Scholar

De Vriendt G, Rigauts H, Meeus L. A semi-automated program for volume measurement in focal hepatic lesions: a first clinical experience. J Belge Radiol 1998; 81: 181-3.Search in Google Scholar

Heussel CP, Meier S, Wittelsberger S, Gotte H, Mildenberger P, Kauczor HU. [Follow-up CT measurement of liver malignoma according to RECIST and WHO vs. volumetry]. [German]. Rofo 2007; 179: 958-64.Search in Google Scholar

Keil S, Plumhans C, Behrendt FF, Stanzel S, Suehling M, Muhlenbruch G, et al. Automated measurement of lymph nodes: a phantom study. Eur Radiol 2009; 19: 1079-86.10.1007/s00330-008-1254-919107487Search in Google Scholar

Keil S, Plumhans C, Behrendt FF, Stanzel S, Suehling M, Muhlenbruch G, et al. Semi-automated quantification of hepatic lesions in a phantom. Invest Radiol 2009; 44: 82-8.10.1097/RLI.0b013e3181911ffa19104439Search in Google Scholar

Cowey CL, Fielding JR, Rathmell WK. The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response. Urology 2010; 75: 1108-13.10.1016/j.urology.2009.06.10519931124Search in Google Scholar

Nathan PD, Vinayan A, Stott D, Juttla J, Goh V. CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies. Cancer Biol Ther 2010; 9: 15-9.10.4161/cbt.9.1.1034020009542Search in Google Scholar

Smith AD, Lieber ML, Shah SN. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol 2010; 194: 157-65.10.2214/AJR.09.294120028918Search in Google Scholar

Petralia G, Preda L, Giugliano G, Jereczek-Fossa BA, Rocca A, D'Andrea G, et al. Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr 2009; 33: 552-9.10.1097/RCT.0b013e31818d446e19638848Search in Google Scholar

Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R, et al. High-grade soft-tissue sarcomas: tumor response assessment - pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology 2009; 251: 447-56.10.1148/radiol.251208140319261927Search in Google Scholar